The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.
about
An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in Cdc34-like enzymesAn allosteric mechanism inferred from molecular dynamics simulations on phospholamban pentamer in lipid membranesEffect of membrane thickness on conformational sampling of phospholamban from computer simulations.Phosphorylation-induced structural changes in smooth muscle myosin regulatory light chainPhosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pumpAcute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.Molecular dynamics simulations reveal a disorder-to-order transition on phosphorylation of smooth muscle myosin.Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A.Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase.Protein Electrostatic Properties Predefining the Level of Surface Hydrophobicity Change upon Phosphorylation.Structure, dynamics, and ion conductance of the phospholamban pentamer.Structural dynamics of muscle protein phosphorylation.Secondary structure, backbone dynamics, and structural topology of phospholamban and its phosphorylated and Arg9Cys-mutated forms in phospholipid bilayers utilizing 13C and 15N solid-state NMR spectroscopy.Thermodynamic and structural basis of phosphorylation-induced disorder-to-order transition in the regulatory light chain of smooth muscle myosin.Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy.Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies.
P2860
Q28478315-9DDC4269-6FDC-454E-B29E-33DE143CD08FQ31007659-653BD7D2-1758-4519-817E-444C69D2F117Q33696035-1AA29B93-5D13-4A58-86D9-6183CF5B9B63Q33929417-C9BF6590-8902-4202-B9D4-797CDD7AE32BQ35063543-67AAD9BD-85D1-4380-9C22-E765F9B85602Q35172673-A186D39F-EDF8-4028-A956-0A1B8AC39101Q35963402-67AB7980-2CB0-4449-AB37-382D7245BCEBQ36137348-05B776DA-662C-44E8-B830-CA488EBE335EQ36795004-03A4579B-4FE8-4AAB-A3B3-98AAF8721AFBQ37053147-5495D2CC-1CC3-4A4E-B3AB-6CB9D2BC3FA5Q37265295-5C08B60C-8000-4BEC-84B6-B9EEF0A783EAQ38038820-02A4C585-5637-42B6-ACC1-7378E5DFA580Q38705315-8B1C1742-6D5D-45BF-B5D3-1119FC4FD149Q40709998-74A4D68D-3CF3-45F2-80F6-2EAE7F7CF41BQ42688806-A662DDC2-8E2E-4F20-BD15-49F7D13A6C15Q54966402-6CC8449A-B408-484E-B74D-0AADE102B66D
P2860
The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The alpha-helical propensity o ...... phosphorylation and mutation.
@ast
The alpha-helical propensity o ...... phosphorylation and mutation.
@en
type
label
The alpha-helical propensity o ...... phosphorylation and mutation.
@ast
The alpha-helical propensity o ...... phosphorylation and mutation.
@en
prefLabel
The alpha-helical propensity o ...... phosphorylation and mutation.
@ast
The alpha-helical propensity o ...... phosphorylation and mutation.
@en
P2860
P1433
P1476
The alpha-helical propensity o ...... f phosphorylation and mutation
@en
P2093
M Germana Paterlini
P2860
P304
P356
10.1529/BIOPHYSJ.104.054460
P407
P577
2005-03-11T00:00:00Z